drugset / Trial / NCT00707993
Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of alogliptin, once daily (QD), compared to glipizide in elderly diabetic patients who have not received treatment or are on a single oral medication.
Timeline
- Start
- 2008-06
- Primary completion
- 2010-08
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alogliptin | Unknown | 25 mg | Oral |
| Comparator | Glipizide | Small molecule | 5 mg | Oral |
| Comparator | Glipizide | Small molecule | 10 mg | Oral |